Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: BJU Int. 2015 Jul 3;117(5):754–760. doi: 10.1111/bju.13186

Table 1.

Patient and tumor characteristics for patients with negative findings at 3-month cystoscopy and available 6-week FISH results

Total Negative FISH Results Positive FISH Results p-value
No. of patients 95 58 37
Age: mean (±SD) 66 ± 11.1 65 ± 12.2 66 ± 9.2 0.544
Sex
 Female 19 (20%) 9 (16%) 10 (27%) 0.171
 Male 76 (80%) 49 (84%) 27 (73%)
Smoker (past or present) 65 (68%) 42 (72%) 13 (35%) 0.376
Grade
 Low 9 (10%) 8 (14%) 1 (3%) 0.086
 High 86 (90%) 50 (86%) 36 (97%)
T Stage
 cTa 38 (40%) 24 (41%) 14 (38%) 0.948
 cT1 50 (53%) 30 (52%) 20 (54%)
 cTis 7 (7%) 4 (7%) 3 (8%)
Concurrent CIS 48 (51%) 21 (36%) 27 (73%) <0.001
Prior Recurrence
  No 16 (17%) 10 (17%) 6 (16%) 0.914
  Single recurrence 43 (45%) 27 (47%) 16 (43%)
  Multiple recurrence 36 (38%) 21 (36%) 15 (41%)
Recurrence 23 (24%) 6 (10%) 17 (46%) <0.001
Progression 17 (18%) 5 (9%) 12 (32%) 0.005
Radical cystectomy 14 (15%) 5 (9%) 9 (24%) 0.043
Death 6 (6%) 3 (5%) 3 (8%) 0.677
Cancer-specific death 4 (4%) 2 (3%) 2 (5%) 0.999

Of 100 patients in the entire cohort, 95 had 6-week FISH results sufficient for analysis; 2 had equivocal results.